United States: Healthcare

Last month the U.S. Attorney's Office for the Northern District of Illinois announced that Walgreens agreed to pay up to $350,000,000 to resolve...

On May 21, 2025, the New York State Liquor Authority (SLA) will hold a public hearing to consider whether to expand the legal operating hours for wine and liquor stores within Albany County.

On May 24, 2025, Robert F. Kennedy, Jr. and the Make America Healthy Again (MAHA) Commission are expected to submit the Make our Children Healthy Again Assessment...

The following discussion highlights key compliance considerations for both existing pharmacies...

On February 26, 2025, the European Economic and Social Committee (EESC) adopted an opinion addressing the integration of robotics and the metaverse in healthcare.

Life Sciences & Healthcare Regulatory partners and former FDA officials Howard Sklamberg and Eva Temkin were featured in FDA Watch's podcast series...

Last month the U.S. Attorney's Office for the Northern District of Illinois announced that Walgreens agreed to pay up to $350,000,000 to resolve...

On May 24, 2025, Robert F. Kennedy, Jr. and the Make America Healthy Again (MAHA) Commission are expected to submit the Make our Children Healthy Again Assessment...

California Governor Gavin Newsom released his "May Revise" budget Wednesday, which takes into account actual state revenues collected through April and updated economic forecasts.

In Otsuka Pharmaceutical Co. v. Sandoz, Inc., the Federal Circuit upheld the district court’s determination that the claims at issue were neither obvious nor invalid under the doctrine of obviousness-type double patenting based on a "lead compound" approach to the obviousness determinations.

After the Supreme Court decided that the personalized medicine method claims at issue in Mayo Collaborative Services v. Prometheus Laboratories, Inc. did not satisfy the patent eligibility requirements of 35 USC § 101.

GlaxoSmithKline and Genentech have settled a U.S. lawsuit related to Genentech's Cabilly II (US 6,331,415) and Cabilly III (US 7,923,221) patents.